FI940696A0 - Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö - Google Patents

Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö

Info

Publication number
FI940696A0
FI940696A0 FI940696A FI940696A FI940696A0 FI 940696 A0 FI940696 A0 FI 940696A0 FI 940696 A FI940696 A FI 940696A FI 940696 A FI940696 A FI 940696A FI 940696 A0 FI940696 A0 FI 940696A0
Authority
FI
Finland
Prior art keywords
preparation
pyrazine derivatives
new pyrazine
new
compounds
Prior art date
Application number
FI940696A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI940696A (fi
Inventor
Herbert Koeppe
Georg Speck
Klaus Stockhaus
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4127026A external-priority patent/DE4127026A1/de
Priority claimed from DE19914130461 external-priority patent/DE4130461A1/de
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of FI940696A0 publication Critical patent/FI940696A0/fi
Publication of FI940696A publication Critical patent/FI940696A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI940696A 1991-08-16 1994-02-15 Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö FI940696A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4127026A DE4127026A1 (de) 1991-08-16 1991-08-16 Neue pyrazinderivate, ihre herstellung und verwendung
DE19914130461 DE4130461A1 (de) 1991-09-13 1991-09-13 Neue pyrazinderivate, ihre herstellung und verwendung
PCT/EP1992/001738 WO1993004048A1 (de) 1991-08-16 1992-07-31 Neue pyrazinderivative, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
FI940696A0 true FI940696A0 (fi) 1994-02-15
FI940696A FI940696A (fi) 1994-02-15

Family

ID=25906394

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940696A FI940696A (fi) 1991-08-16 1994-02-15 Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö

Country Status (23)

Country Link
EP (1) EP0598770B1 (hu)
JP (1) JPH06509798A (hu)
AT (1) ATE159250T1 (hu)
AU (1) AU669122B2 (hu)
CA (1) CA2115755A1 (hu)
CZ (1) CZ280760B6 (hu)
DE (1) DE59208974D1 (hu)
DK (1) DK0598770T3 (hu)
ES (1) ES2108129T3 (hu)
FI (1) FI940696A (hu)
GR (1) GR3025742T3 (hu)
HK (1) HK1003137A1 (hu)
HU (1) HUT67661A (hu)
IE (1) IE922592A1 (hu)
IL (1) IL102814A0 (hu)
MX (1) MX9204637A (hu)
NO (1) NO301542B1 (hu)
NZ (1) NZ243959A (hu)
RU (1) RU2124008C1 (hu)
SG (1) SG46307A1 (hu)
SK (1) SK17594A3 (hu)
TW (1) TW213903B (hu)
WO (1) WO1993004048A1 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645969B1 (en) 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
IL109570A0 (en) * 1993-05-17 1994-08-26 Fujisawa Pharmaceutical Co Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
DE4325822A1 (de) * 1993-07-31 1995-02-02 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US5852046A (en) * 1993-08-03 1998-12-22 Hoechst Aktiengesellschaft Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
DE4337609A1 (de) * 1993-11-04 1995-05-11 Boehringer Ingelheim Kg Neue Pyrazincarboxamidderivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE4412334A1 (de) * 1994-04-11 1995-10-19 Hoechst Ag Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US5760230A (en) * 1996-10-11 1998-06-02 Bayer Aktiengesellschaft 4, 4'-bridged bis-2, 4-diaminoquinazolines
US6420354B1 (en) * 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
EP1182194A4 (en) 1999-06-03 2004-02-11 Takeda Chemical Industries Ltd PERNASAL COMPOSITIONS
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
US6156758A (en) * 1999-09-08 2000-12-05 Isis Pharmaceuticals, Inc. Antibacterial quinazoline compounds
PL212089B1 (pl) * 2002-03-13 2012-08-31 Janssen Pharmaceutica Nv Związki heterocykliczne jako inhibitory deacetylazy histonowej, kompozycja farmaceutyczna je zawierająca, ich zastosowanie, sposób wytwarzania, sposób wykrywania lub identyfikacji HDAC oraz kompozycja
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
WO2005023183A2 (en) 2003-08-28 2005-03-17 Nitromed, Inc. Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CA2592900A1 (en) 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
JP2008531579A (ja) 2005-02-24 2008-08-14 ニトロメッド インコーポレーティッド 酸化窒素増強利尿化合物、組成物および使用方法
DE102008061247A1 (de) * 2008-12-10 2010-06-24 Christian-Albrechts-Universität Zu Kiel Inhibitoren der Dimethylarginin Dimethylaminohydrolase
WO2012031563A1 (zh) * 2010-09-10 2012-03-15 杭州本生药业有限公司 杂环氨基小檗胺衍生物、其制备方法和应用
CN110041291B (zh) * 2018-01-15 2021-02-26 北京采瑞医药科技研究院有限公司 一种玛咖酰胺衍生物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL299931A (hu) * 1962-10-30
US3527758A (en) * 1967-04-13 1970-09-08 Merck & Co Inc Process for the preparation of pyrazinoylguanidines from a pyrazinoic azide and a guanidine
US3539569A (en) * 1968-08-21 1970-11-10 Merck & Co Inc Preparation of pyrazinoylguanidines from pyrazinoylureas
NL7803906A (nl) * 1978-04-12 1979-10-16 Noordvos Schroeven Bv Werkwijze, inrichting en propeller voor het verdelen van een gasvormig, poedervormig of vloeibaar materiaal in een vloeistof.

Also Published As

Publication number Publication date
CZ280760B6 (cs) 1996-04-17
CZ33794A3 (en) 1994-07-13
IL102814A0 (en) 1993-01-31
NO940523L (no) 1994-02-15
JPH06509798A (ja) 1994-11-02
NO940523D0 (no) 1994-02-15
SG46307A1 (en) 1998-02-20
TW213903B (hu) 1993-10-01
AU669122B2 (en) 1996-05-30
NZ243959A (en) 1995-07-26
HK1003137A1 (en) 1998-10-09
DK0598770T3 (da) 1997-12-15
MX9204637A (es) 1993-02-01
NO301542B1 (no) 1997-11-10
SK17594A3 (en) 1994-12-07
ES2108129T3 (es) 1997-12-16
EP0598770A1 (de) 1994-06-01
IE922592A1 (en) 1993-02-24
AU2387092A (en) 1993-03-16
WO1993004048A1 (de) 1993-03-04
RU94015265A (ru) 1997-02-20
HUT67661A (en) 1995-04-28
RU2124008C1 (ru) 1998-12-27
DE59208974D1 (de) 1997-11-20
HU9400430D0 (en) 1994-05-30
ATE159250T1 (de) 1997-11-15
EP0598770B1 (de) 1997-10-15
FI940696A (fi) 1994-02-15
CA2115755A1 (en) 1993-03-04
GR3025742T3 (en) 1998-03-31

Similar Documents

Publication Publication Date Title
FI940696A (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
IL109526A0 (en) Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
ATE124401T1 (de) Neue arylpyridazine, ihre herstellung, verwendung und sie enthaltende arzneimittel.
SE8700498D0 (sv) Novel pharmaceologically active compounds
AU2724292A (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-d-neuraminic acid
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
BG100069A (en) Amidine derivatives containing heterocylic groups, their preparation and application
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
SE8600658D0 (sv) Novel composition of matter
AU1891683A (en) Substituted 1-phenyl-isoquinoline anti-arrythmic agents
AU530678B2 (en) Phosphono-hydroxy-acetic acid
ZA874470B (en) New tetrahydrobenzothiazoles,and the preparation and use thereof
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
BG90609A (bg) Производни на пирола, методи за получаване и приложение
FR2676448B1 (fr) Nouveaux derives amidiques de 1-amino octahydropyrido [2,1-c] [1,4] oxazine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
TH2131B (th) การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้
DK214884A (da) Chlorphenoxyacetatderivat